Category: Henry Schein Inc.
Henry Schein acquires 5 dental software, lab and distribution business from Belgium's Arseus for an undisclosed amount.
Healthcare giant Henry Schein (NSDQ:HSIC) agreed to pay an undisclosed amount to acquire 5 dental businesses from Belgium-based Arseus, the companies announced this week.
New York medtech maker Henry Schein adds another $300 million to its share buyback program as it closes in on the 1st $300 million.
Melville, N.Y.-based medical device maker Henry Schein (NSDQ:HSIC) doubled down on its share repurchasing program as it crept closer to its initial $300 million cap.
Ali Haghighi-Mood, the former president & CEO of Cambridge Heart, and chairman Roderick de Greef both resign for unnamed reasons.
Cambridge Heart (NSDQ:CAMH) said chairman and interim president Roderick de Greef and former president & CEO Ali Haghighi-Mood have both resigned from the medical device company.
Henry Schein Inc. says it plans to acquire a 60% stake in dental implant maker BioHorizons for an undisclosed amount.
Henry Schein (NSDQ:HSIC) said it plans to pick up a 60% stake in dental implant maker BioHorizons for an undisclosed amount.
Medical device companies including Cardinal Health and Henry Schein were among the firms awarded contracts and extensions worth nearly $84 million by the U.S. Defense Dept. today.
By Chris Walker
The U.S. Defense Dept. issued $83.9 million worth of contracts to 4 medical device companies, according to the agency's daily press release.
Henry Schein cut some dead weight by shedding a distributor in the Middle East that wasn't turning a profit.
Henry Schein (NSDQ:HSIC) said it's shed of 1 of its unprofitable wholesale dental distributors in the Middle East, a move that will cost the company between $11 and $13 million.
InspireMD nets nearly $23 million from a public stock offering, saying it plans to use the proceeds to pursue U.S. approval of its MGuard coronary and carotid stents.
InspireMD (OTC:NSPR) said it added some $23 million to its coffers in a public stock offering.
The Tel Aviv-based medical device company makes the MGuard device, designed to protect against embolism after stenting procedures.
Zoll Medical Corp.
, BSD Medical Corp.
, Cardinal Health
, Combat Medical Systems
, Dental Health Products
, Henry Schein Inc.
, MiMedx Group Inc.
, Nonin Medical Inc.
, Reflectance Medical
, Terumo Corp.